Jounce Therapeutics to Present at Upcoming Investor Conferences in June
June 11, 2019 08:00 ET
|
Jounce Therapeutics, Inc.
CAMBRIDGE, Mass., June 11, 2019 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and...